AdaptHealth Corp. Q3 2025 results

By doing so, it allowed us to better manage our resources, and that decision was a key contributor to the mid-single-digit organic growth each segment produced this quarter. We are continuing to demonstrate progress across all three value drivers: growth, profitability, and risk profile. Starting with growth, our third quarter revenue was $820.3 million, up 1.8% from prior year quarter. Organic revenue growth, which does not include changes in revenue from divestitures or acquisitions, was 5.1% versus the prior year quarter, with strength across each of our four reportable segments.

We experienced robust year-over-year growth in our wellness at home segment, driven by orthotics and hospice. In diabetes health, we delivered the first quarter of revenue growth since Q1 2024. Moving to profitability, our third quarter adjusted EBITDA was $170.1 million, up 3.5% from the prior year quarter and above the high end of our guidance range. Debt reduction remains among our highest capital allocation priorities, as we believe a strong balance sheet is essential to unlocking and sustaining value for shareholders.

Now, with a standard operating model across the country, we can more efficiently deploy operational improvements and technology solutions in a timely manner and at scale. Looking forward, as we deploy technology that allows more patients to self-serve, this new call center will supplement the local branches with increased capacity to manage the most critical patient concerns. We continue to believe that there is significant potential to deploy AI and automation across our business. For example, in the third quarter, automation enabled the revenue cycle management team to reduce its reliance on offshore labor by approximately 5%.